Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Progressive Muscular Atrophy: early-phase trial registry
2 of 5 indexed Progressive Muscular Atrophy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Progressive Muscular Atrophy: 5 US clinical trials tracked, 2 recruiting.
Progressive Muscular Atrophy is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Miami, running 3 of these trials.
Enrollment posture brief
Registry condition progressive-muscular-atrophy
OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Progressive Muscular Atrophy lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Progressive Muscular Atrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Progressive Muscular Atrophy is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Progressive Muscular Atrophy research.
University of Miami accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Progressive Muscular Atrophy enrolment sits around 217 participants.
Median target enrolment is 217 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Progressive Muscular Atrophy research leans observational.
1 interventional and 4 observational studies make up this index (20% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Clinical Procedures to Support Research in ALS
University of Miami
NCT03489278
Digital Assessment of Speech and Fine Motor Control in ALS
Milton S. Hershey Medical Center
NCT06315673
TRIAL READY (Clinical Trial Readiness)
University of Miami
NCT03912987
Phenotype, Genotype and Biomarkers 2
University of Miami
NCT04875416
Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
Duke University
NCT00324454
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Progressive Muscular Atrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Progressive Muscular Atrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Progressive Muscular Atrophy page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Progressive Muscular Atrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Miami sponsors the most Progressive Muscular Atrophy trials on record, review their full trial history before evaluating a specific study. See University of Miami's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Progressive Muscular Atrophy condition card totals 5 registered trials; most-linked intervention Levetiracetam; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.